LATEST
Silgan / Trivium: minority stakeBF International Best Fields Best Food / DiagramOpenWorld agreed to acquire Blocksight HoldingsMerck KGaA agreed to acquire Silence TherapeuticsLarry A. Powalisz / Adia LabsTTM Technologies / Ophir® Optics businessTradeweb Markets agreed to acquire Trumid HoldingsCentrus Energy / Westerman HoldingsTCGX Acquisition / TriGemX BioArlington Capital Partners / Gooch & HousegoJanus Henderson Investors agreed to acquire four mutual funds managed by Nicholas CompanyPlatinum Equity / Trime: majority stake
Open App
Agreement signedPublished 1 Mar 2024

Pierre Fabre Médicament, SAS /
Kinnate Biopharma Inc.

Pierre Fabre takes on Kinnate’s pan-RAF program assets

Buy side: Pierre Fabre Médicament, SAS
Buy sidePierre Fabre Médicament, SAS
Target: Kinnate Biopharma Inc.
TargetKinnate Biopharma Inc.
Source · 1 Mar 2024Source-verified
See the source
Buy side: Pierre Fabre Médicament, SAS
Buy sidePierre Fabre Médicament, SAS
Target: Kinnate Biopharma Inc.
TargetKinnate Biopharma Inc.
01 / BuyerPierre Fabre Médicament, SAS
02 / TargetKinnate Biopharma Inc.
Source-verified
01

What happened

Pierre Fabre Médicament, SAS purchased Kinnate Biopharma Inc.’s exarafenib and other pan-RAF assets. The transaction transfers global rights, with Pierre Fabre taking responsibility for ongoing program costs.

Kinnate will receive up to $31.0 million, including $500,000 at closing and up to $30.5 million tied to specified development and regulatory milestones.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Pierre Fabre takes on Kinnate’s pan-RAF program assets

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.